Mark G. Currie

Flinders University — Australia

Medicine · Health Sciences

69h-index20.8kcitations313works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gastrointestinal motility and disorders(68), Nitric Oxide and Endothelin Effects(62), Gastroesophageal reflux and treatments(28), Helicobacter pylori-related gastroenterology studies(22), Eicosanoids and Hypertension Pharmacology(22)

Publications312 total

Burnout in physiotherapists and occupational therapists working in the Australian community disability sector under the national disability insurance scheme: a qualitative study
Disability and Rehabilitation·2025· 1 citedOpen Access
<scp>FAAH</scp> inhibitor <scp>URB597</scp> shows anti‐hyperalgesic action and increases brain and intestinal tissues fatty acid amides in a model of <scp>CRF<sub>1</sub></scp> agonist mediated visceral hypersensitivity in male rats
Neurogastroenterology & Motility·2024· 3 citedOpen Access
The Encounter with Structuralism and the Invention of Poststructuralism
Edinburgh University Press eBooks·2022
Jean-Paul Sartre (1905-1980), Albert Camus (1913-1960) and Existentialism
Edinburgh University Press eBooks·2022
Time–Space Compression
Cambridge University Press eBooks·2022· 1 cited
The CNS-penetrant soluble guanylate cyclase stimulator CYR119 attenuates markers of inflammation in the central nervous system
Journal of Neuroinflammation·2021· 31 citedOpen Access
The CNS-Penetrant Soluble Guanylate Cyclase Stimulator CY6463 Reveals its Therapeutic Potential in Neurodegenerative Diseases
Frontiers in Pharmacology·2021· 33 citedOpen Access
Event
2021
5. Anticipation / Unexpected
Time·2020
Effects of the Soluble Guanylate Cyclase Stimulator Praliciguat in Diabetic Kidney Disease
Clinical Journal of the American Society of Nephrology·2020· 37 citedOpen Access
Effect of Praliciguat, a Once-Daily, Oral Soluble Guanylate Cyclase Stimulator, on Albuminuria in Patients with Diabetic Kidney Disease: A Randomized, Double-Blind, Phase 2 Trial
Journal of the American Society of Nephrology·2020· 1 cited
Praliciguat inhibits progression of diabetic nephropathy in ZSF1 rats and suppresses inflammation and apoptosis in human renal proximal tubular cells
American Journal of Physiology-Renal Physiology·2020· 27 citedOpen Access
An impaired natriuretic peptide hormone system may play a role in COVID‐19 severity in vulnerable populations
FASEB BioAdvances·2020· 8 citedOpen Access
1081-P: Metabolic Effects of Praliciguat, Empagliflozin, and Their Combination in Rats with Programmed Hypertension and Early Exposure to High-Fat Diet
Diabetes·2020
1073-P: Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Soluble Guanylate Cyclase Stimulator Praliciguat in Patients with Diabetic Kidney Disease
Diabetes·2020· 1 cited
An Impaired Natriuretic Peptide Hormone System May Play a Role in COVID-19 Severity in Vulnerable Populations
2020· 3 cited
124-LB: Praliciguat, a Clinical-Stage Soluble Guanylate Cyclase (sGC) Stimulator, Improved Oral Glucose and Lipid Handling and Slowed Diabetic Weight Loss in TALLYHO Mice
Diabetes·2020
Olinciguat, an Oral sGC Stimulator, Exhibits Diverse Pharmacology Across Preclinical Models of Cardiovascular, Metabolic, Renal, and Inflammatory Disease
Frontiers in Pharmacology·2020· 33 citedOpen Access
SUN-662 Praliciguat, a Clinical-Stage Soluble Guanylate Cyclase Stimulator, Improves Lipid Handling and Insulin Sensitivity in Diet-Induced Obese Mice
Journal of the Endocrine Society·2020Open Access
Pharmacokinetics, mass balance, tissue distribution, metabolism, and excretion of praliciguat, a clinical‐stage soluble guanylate cyclase stimulator in rats
Pharmacology Research & Perspectives·2020· 8 citedOpen Access
page 1 of 16Next →

Frequent Co-authors

Thomas P. Misko(12), Caroline B. Kurtz(12), Philip Needleman(11), Pamela T. Manning(11), Jeffrey M. Johnston(9), James E. MacDougall(7), David M. Geller(6), Anthony Lembo(6), Bernard J. Lavins(6), Karen Seibert(5), Daniela Salvemini(5), William M. Moore(5), Jaime L. Masferrer(4), Barbara R. Cole(4), Daniela Salvemini(4), Steven J. Shiff(4), Donald A. Fitch(4), Jane R. Connor(4), Gerhard Hannig(4), Leonard R. Forte(4)